Januvia and Byetta may increase the risk of pancreatic cancer
Januvia – a prescription pill that helps lower blood sugar levels in adults with type 2 diabetes.
Byetta – an injectable prescription medication that helps improve blood sugar levels in adults with type 2 diabetes.
In September of 2009 the FDA (Food and Drug Administration) issued a revision of the warning label on Januvia to include the risks of Januvia pancreatitis and Januvia cancer. To view the FDA Januvia Medication Guide, click here.
FDA data from thousands of patients concluded that taking Byetta had a 2.95 times greater risk of developing pancreatic cancer than those on an unrelated diabetes medication. Byetta now carries the warning label issued by the FDA as well. To view the FDA Byetta Medication Guide, click here.
Both Januvia and Byetta have serious adverse effects that can potentially be fatal, including, but not limited to:
- Pancreatitis – An inflammation of the pancreas that can be fatal – patients should stop taking either medication if experiencing: Severe pain in the upper stomach (abdomen) and/or back, Nausea and Vomiting, Loss of appetite, Fever, Sore throat, Headache, A Skin Rash that is red or purple in color and may be blistering and peeling, Fast Heart Rate, Loss of Appetite.
- Kidney Problems – Kidney function problems including kidney failure, the need for dialysis has been reported.
- Stomach Problems, Nausea, Vomiting, Diarrhea, Dizziness, Acid Stomach, Weakness, Jittery Feeling, Headache, Constipation
If you believe that you or a loved one has suffered injury or death due to Januvia or Byetta, we invite you to contact our attorneys at The Maher Law Firm or Frank Eidson Attorney At Law. We are currently investigating potential Januvia and Byetta lawsuit claims, you may have a right to compensation for your injuries.
